IMMUNE RESPONSE TO SARS-COV-2 VACCINES AMONG HAEMODIALYSIS PATIENTS

被引：0
|
作者：
Perysinaki, Garyfalia [1 ]
Papadaki, Panagiota [1 ]
Passam, Andreas-Michahl [1 ]
Ntaountaki, Irini [1 ]
机构：
[1] Rethymnon Gen Hosp, Nephrol, Rethimnon, Greece
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2022年 / 37卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
MO844
引用
收藏
页码：I607 / I607
页数：1
相关论文
共 50 条
  • [21] SARS-CoV-2 vaccines in patients with SLE
    Tang, Wei
    Askanase, Anca D.
    Khalili, Leila
    Merrill, Joan T.
    LUPUS SCIENCE & MEDICINE, 2021, 8 (01):
  • [22] Humoral response to SARS-CoV-2 vaccination in haemodialysis patients and a matched cohort
    Zhao, Tianchen
    Nishi-Uchi, Takamitsu
    Omata, Fumiya
    Takita, Morihito
    Kawashima, Moe
    Nishikawa, Yoshitaka
    Yamamoto, Chika
    Kobashi, Yurie
    Kawamura, Takeshi
    Shibuya, Kenji
    Kazama, Junichiro
    Shineha, Ryuzaburo
    Tsubokura, Masaharu
    BMJ OPEN, 2022, 12 (11):
  • [23] The Safety Profile of SARS-CoV-2 Vaccines Among Patients with Immune-Mediated Rheumatic Diseases
    Gomez-Puerta, Jose A.
    Sapena, Nuria
    Sarmiento-Monroy, Juan C.
    Belen Azuaga, Ana
    Ruiz-Esquide, Virginia
    Frade-Sosa, Beatriz
    Bassas, Marta
    Morla, Rosa
    Ponce, Andres
    Canete, Juan D.
    Ramirez, Julio
    Villella, Anna
    Trilla, Antoni
    Sanmarti, Raimon
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 223 - 225
  • [24] Immune response to SARS-CoV-2 vaccines in patients with multiple sclerosis in Argentina: prospective and multicenter study
    Vazquez, G.
    Lamas, P.
    Remolins, C.
    Appiani, F.
    Martinez, A.
    Curbelo, M. C.
    Pirola, D.
    Natalia, B.
    Chuluyan, E.
    Carra, A.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 879 - 879
  • [25] Immune response against SARS-CoV-2 vaccines in treatment-naive multiple sclerosis patients
    Ozakbas, S.
    Baba, C.
    Samadzade, U.
    Kaya, E.
    Ozcelik, S.
    Ozdogar, A. T.
    Dogan, Y.
    Cevik, S.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 776 - 776
  • [26] Comment on “immune response to SARS-CoV-2 mRNA vaccines in patients treated with either Ibrutinib or Rituximab”
    Rujittika Mungmunpuntipantip
    Viroj Wiwanitkit
    Clinical and Experimental Medicine, 2023, 23 : 955 - 955
  • [27] Comment on "immune response to SARS-CoV-2 mRNA vaccines in patients treated with either Ibrutinib or Rituximab"
    Mungmunpuntipantip, Rujittika
    Wiwanitkit, Viroj
    CLINICAL AND EXPERIMENTAL MEDICINE, 2023, 23 (03) : 955 - 955
  • [28] Antibody response to SARS-CoV-2 booster vaccines
    Loving, Hanna S.
    Sacks, David B.
    Harb, Roa
    CLINICAL BIOCHEMISTRY, 2022, 107 : 80 - 82
  • [29] SARS-CoV-2 Vaccines
    Creech, C. Buddy
    Walker, Shannon C.
    Samuels, Robert J.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 325 (13): : 1318 - 1320
  • [30] Olfactory immune response to SARS-CoV-2
    Wellford, Sebastian A.
    Moseman, E. Ashley
    CELLULAR & MOLECULAR IMMUNOLOGY, 2024, 21 (02) : 134 - 143
12345